Resources to help protect you against the flu

RESOURCES

Resources to Help Protect You Against the Flu

FLU TIPS AND FACTS

Click on the image below to download and print Tips on the Flu
or an Educational Flu Pamphlet for Patients.

Tips on the Flu Tips on the Flu

Educational Flu Pamphlet Educational Flu Pamphlet

FREQUENTLY ASKED QUESTIONS

Click on the image below to download and print a downloadable PDF
of Frequently Asked Questions about Afluria® and the flu shot.

Educational Flu Pamphlet Frequently Asked Questions

KEEP THE FLU OFF YOUR SCHEDULE. TALK TO YOUR DOCTOR OR PHARMACIST ABOUT GETTING AFLURIA.

seqirus

The product information presented on this site is for U.S. residents only. Afluria® and Seqirus™ are trademarks of Seqirus UK Limited or its affiliates. PharmaJet® and Stratis® are registered trademarks of PharmaJet Inc. © 2017 Seqirus USA Inc. and/or its affiliates. All rights reserved. 1020 First Avenue, PO Box 60446, King of Prussia, PA 19406-0446

www.seqirus-us.com AFL15-02-0006(1) 08/2016

Important Safety Information

What is Afluria® Influenza Vaccine?

Afluria is an inactivated (virus is not alive) influenza vaccine used for immunization against influenza disease caused by influenza virus subtypes A and B present in the vaccine.

Afluria cannot give you the flu. It stimulates the immune system to produce antibodies that can help to protect against influenza; the full effect of the vaccine is generally achieved approximately three weeks after receiving your vaccination. Annual vaccination is recommended against influenza.

Who should receive Afluria?

Afluria administered by needle and syringe can be used in patients five years of age and older.

Afluria can be used with the PharmaJet® Stratis® Needle-Free Injection System in patients 18 through 64 years of age.

Who should not receive Afluria?

Do not receive Afluria if you have an egg allergy. Talk with your doctor if you have ever had a severe allergic reaction after receiving a flu vaccine. Talk with your doctor if you have ever had Guillain-Barré Syndrome (GBS).

Talk with your doctor if you get infections easily, are pregnant, or nursing.

What are the side effects of Afluria?

Fever side effects were observed in children 5 through 8 years of age in 2010.

The most common injection-related adverse reactions in children (5 through 17 years of age) administered Afluria with needle and syringe were pain, redness, and swelling. The most common side effects were headache, muscle pain, irritability, feeling tired and sick, and fever.

The most common injection-related adverse reactions in adults (18 through 64) administered Afluria with needle and syringe were tenderness, pain, swelling, redness, and itching. The most common side effects in adults were muscle aches, headache, and feeling tired and sick.

The most common injection-related adverse reactions in adults (18 through 64) administered Afluria by the PharmaJet Stratis Needle-Free Injection System up to 7 days after vaccination were tenderness, swelling, pain, redness, itching, and bruising. The most common side effects were muscle pain, feeling tired and sick, and headache.

In adults age 65 and older, when administered Afluria by needle and syringe, the most common injection-related adverse reactions were tenderness and pain.

What do I do if I have side effects?

Report any severe or unusual side effects to your healthcare provider.

Please see the full prescribing information for Afluria for further information. To report SUSPECTED ADVERSE REACTIONS, contact Seqirus USA Inc. at 1 855 358 8966 or VAERS at 1-800-822-7967 or www.vaers.hhs.gov.

You are also encouraged to report negative side effects of prescription drugs to the FDA.
Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088.

The information provided here is not comprehensive. To learn more, talk about Afluria with your healthcare provider or pharmacist. The FDA-approved product labeling can be found at http://www.afluria.com/prescribing-information.aspx or 1 855 358 8966.

US/AFL/0716/0045c 07/2016